Medivir in brief

Medivir focuses on the discovery and development of transformative cancer drugs. To do this efficiently and with a high success rate, we rely on our scientific knowledge, balanced project portfolio, collaborative culture and extensive industry experience.

Medivir is listed on the Nasdaq Stockholm Mid Cap List.

Medivir corporate presentation

Read more about our research and development

Read about our current projects